Evidence map›Paper›PMID 37012537›Full record

ReviewCurrent HIV/AIDS reports2023

Mapping Community-Engaged Implementation Strategies with Transgender Scientists, Stakeholders, and Trans-Led Community Organizations.

Arjee Restar, Brian J Minalga, Ma Irene Quilantang, Tyler Adamson, Emerson Dusic, Leigh-Ann van der Merwe, Greg Millet, Danvic Rosadiño, Tanya Laguing, Elle Lett and 10 more

Open access · hybridAbstract readReview
In one paragraph

Review in Current HIV/AIDS reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
9.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 13 institutions in 4 countries.

Arjee RestarDepartment of Epidemiology, University of Washington School of Public Health, Seattle, WA, USA. restar@uw.edu.ORCID 0000-0003-2992-8198
Brian J MinalgaFred Hutchinson Cancer Center, Seattle, WA, USA.
Ma Irene QuilantangDepartment of Behavioral and Social Sciences, Brown University School of Public Health, Providence, RI, USA.
Tyler AdamsonDepartment of Health Policy and Management, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.
Emerson DusicDepartment of Biostatistics, University of Washington School of Public Health, Seattle, WA, USA.
Leigh-Ann van der MerweSocial, Health and Empowerment Feminist Collective of Transgender Women of Africa, East London, South Africa.
Greg MilletThe Foundation for AIDS Research, amfAR, amfAR, Washington, D.C, USA.
Danvic RosadiñoLoveYourself Inc, Manila, Philippines.
Tanya LaguingLoveYourself Inc, Manila, Philippines.
Elle LettComputational Health Informatics Program, Boston Children's Hospital, Boston, MA, USA.
Avery EverhartDepartment of Health Behavior and Health Education, School of Public Health, University of Michigan, Ann Arbor, MI, USA.
Gregory PhillipsDepartment of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Rena JanamnuaysookInstitute of HIV Research and Innovation, Bangkok, Thailand.
Pich SeekaewInstitute of HIV Research and Innovation, Bangkok, Thailand.
Kellan BakerDepartment of Health Policy and Management, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.
Florence AshleyFaculty of Law and Joint Centre for Bioethics, University of Toronto, Toronto, ON, Canada.
Jeffrey WickershamSection of Infectious Disease, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
Stephaun E WallaceFred Hutchinson Cancer Center, Seattle, WA, USA.
Don OperarioDepartment of Behavioral, Social, and Health Education Sciences, Emory Rollins School of Public Health, Atlanta, GA, USA.
Kristi E GamarelDepartment of Health Behavior and Health Education, School of Public Health, University of Michigan, Ann Arbor, MI, USA.
University of Washington · USJohns Hopkins University · USUniversity of Michigan · USAmerican Foundation for AIDS Research · USBoston Children's Hospital · USBrown University · USFred Hutch Cancer Center · USHIV Netherlands Australia Thailand Research Collaboration · THNorthwestern University · USSirindhorn College of Public Health · THTaguig City University · PHUniversity of Toronto · CAYale University · US

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI CONNIE L CELUM · 1988 to 2026
$104.9M
Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Scientific/Technical CoreP2CHD041028 · NICHD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Sarah A. Burgard · 2017 to 2026
$6.5M
Training Program for Scientists Conducting Research to Reduce HIV Health DisparitR25MH067127 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Emily A Arnold, Torsten Brian Neilands · 2003 to 2026
$5.4M
Research Education Institute for Dynamic Scholars (REIDS)R25MH087217 · NIMH · YALE UNIVERSITY · PI Jasmine Abrams, Trace S Kershaw · 2010 to 2026
$3.9M
A couples-based approach to HIV prevention for transgender women and their male partnersR01MH115765 · NIMH · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GAMAREL, KRISTI E, OPERARIO, DON · 2018 to 2022
$2.9M
Stigma Reduction and Gender Affirmation to Promote HIV Prevention/Testing in Trans WomenR21TW012010 · FIC · EMORY UNIVERSITY · PI OPERARIO, DON · 2021 to 2022
$401k
FIC NIH HHS R21 TW012010NCATS NIH HHS UL1 TR001863NIAID NIH HHS P30 AI027757NICHD NIH HHS P2C HD041028NIMH NIH HHS R01 MH115765NIMH NIH HHS R25 MH067127NIMH NIH HHS R25 MH087217
6 · The paper itself

Abstract

purpose of reviewPre-exposure prophylaxis (PrEP) represents one of the most effective methods of prevention for HIV, but remains inequitable, leaving many transgender and nonbinary (trans) individuals unable to benefit from this resource. Deploying community-engaged PrEP implementation strategies for trans populations will be crucial for ending the HIV epidemic. RECENT

findingsWhile most PrEP studies have progressed in addressing pertinent research questions about gender-affirming care and PrEP at the biomedical and clinical levels, research on how to best implement gender-affirming PrEP systems at the social, community, and structural levels remains outstanding. The science of community-engaged implementation to build gender-affirming PrEP systems must be more fully developed. Most published PrEP studies with trans people report on outcomes rather than processes, leaving out important lessons learned about how to design, integrate, and implement PrEP in tandem with gender-affirming care. The expertise of trans scientists, stakeholders, and trans-led community organizations is essential to building gender-affirming PrEP systems.

Indexed as

Anti-HIV AgentsEpidemicsHIV InfectionsPre-Exposure ProphylaxisTransgender PersonsFemaleGender IdentityHumansMaleAnti-HIV AgentsGender-affirming careHIV preventionImplementationNonbinaryPrEPTransgender

Identifiers

PMID37012537
PMCPMC10071255
OpenAlexW4362522277

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.